Vitreocorneal touch syndrome: management by vitreous face discission via posterior approach.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D001082:Aqueous Humor; D001285:Atropine / Q000627:therapeutic use; D002387:Cataract Extraction / Q000009:adverse effects*; D003042:Cocaine / Q000627:therapeutic use; D003315:Cornea; D003517:Cyclopentanes / Q000627:therapeutic use; D005128:Eye Diseases / Q000188:drug therapy / Q000209:etiology* / Q000601:surgery; D005990:Glycerol / Q000627:therapeutic use; D006801:Humans; D007498:Iris / Q000601:surgery; D008353:Mannitol / Q000627:therapeutic use; D008722:Methods; D008744:Methylamines / Q000627:therapeutic use; D010648:Phenylacetates / Q000627:therapeutic use; D010656:Phenylephrine / Q000627:therapeutic use; D011183:Postoperative Complications / Q000188:drug therapy / Q000601:surgery; D014822:Vitreous Body
D000305:Adrenal Cortex Hormones; D003517:Cyclopentanes; D008744:Methylamines; D010648:Phenylacetates; D010656:Phenylephrine; D008353:Mannitol; D001285:Atropine; D003042:Cocaine; D005990:Glycerol